Having done a research fellowship at Memorial Sloan Kettering Cancer Center,Tabar joined the faculty. At present,she is the Theresa C. Feng Chair for Neurosurgical Oncology and the Vice Chair for Neurosurgical Research and Education.[2] In December 2017,she was named Chair of the Department of Neurosurgery at Memorial Sloan Kettering Cancer Center,succeeding to Philip Gutin,MD.[3][4]
Viviane Tabar is also the founding Director of the Multidisciplinary Pituitary and Skull Base Tumor Center at Memorial Sloan Kettering Cancer Center.[5]
Work
Tabar's specialty is intraoperative brain mapping techniques.[2]
Her research is in stem cell biology,and she is one of the leaders of the New York State consortium for the development of human embryonic stem cell–derived dopamine neurons for Parkinson's disease.[6] She has devised strategies for cell-based therapies for the repair of radiation-induced brain injury. Her lab has used pluripotent stem cells for brain tumor modeling,resulting in novel insights into the biology of gliomas and to the discovery of candidate therapeutic targets for brain tumors. She has a clinical expertise in the surgical management of brain tumors such as complex gliomas,meningiomas and skull base tumors.[7] In 2010,with her research team of the Sloan-Kettering Cancer Center,she demonstrated the fact that tumorous blood vessel cells may come from tumor cells as a way to create their own blood supply. Those results contributed to demonstrate the great plasticity of tumors.[8]
A prolific author,she has written dozens of widely cited publications.
Viviane Tabar is married to Lorenz Studer. They have two children together.[14][11] They both work at the Sloan Kettering Institute heading medical research projects.[15]
This page is based on this Wikipedia article Text is available under the CC BY-SA 4.0 license; additional terms may apply. Images, videos and audio are available under their respective licenses.
